High quality ELISAs
Developed and manufactured by Biomedica

Fibroblast growth factor 23 (FGF23) plays a key role in mineral and bone disorders related to chronic kidney disease (CKD). Elevated FGF23 levels are linked to a higher risk of anemia in non-hemodialysis CKD and in patients undergoing hemodialysis. Researchers have identified a strong relationship between FGF23 and erythropoietin (EPO) resistance in hemodialysis (HD) patients. [...]

Thirty-Year Outcomes of Immunosuppression Modulation Over the past six decades, organ transplantation, especially pediatric liver transplantation, has revolutionized medical care by offering life-saving treatment options for children with end-stage liver disease (1). In a recent study, researchers investigated on how immunosuppressive therapy affects liver transplant outcomes in children during a thirty-year follow-up (2). Although pediatric [...]

Our EZ4U Cell Proliferation and Cytotoxicity Assay was successfully applied in a recent study investigating novel therapeutic options for Cutaneous T-cell lymphoma (CTCL), a type of skin cancer that can also affect the blood (1). Extracorporeal photopheresis (ECP) is an immunomodulating photochemotherapy that has been linked to improved overall survival in the treatment of CTCL [...]